DCW Q2 FY27 Earnings Call — Analysis (NSE: DCW)

DCW reported Q2FY27 revenue of ₹663 Cr (+23% YoY) with EBITDA recovering sequentially to ₹55 Cr (+32% QoQ), supported by basic chemicals turnaround despite near-term CPVC spread compression.

· Analysis by Alpha Inflection

Result quality: stable — Results context unavailable. Management sentiment: neutral.

The take

Q2FY27 Revenue from Operations ₹663 Cr ( +23% YoY ) . New story: Specialty Chemicals Transformation .

Results

Revenue grew 23% YoY to ₹663 Cr; EBITDA fell 13% YoY but rebounded 32% QoQ to ₹55 Cr with an EBITDA margin of 8.2%.

Financial highlights

DCW Q2 FY27 reported figures
MetricValueChangeBasis
Revenue from Operations₹663 Cr+23%yoy · Q2FY27
Revenue from Operations₹663 Cr+22%qoq · Q2FY27
Specialty Chemicals Revenue₹663 Cr+32%yoy · Q2FY27 · segment revenue growth
Basic Chemicals Revenue₹663 Cr+20%yoy · Q2FY27 · segment revenue growth
EBITDA₹55 Cr-13%yoy · Q2FY27 · including other income
EBITDA₹55 Cr+32%qoq · Q2FY27 · including other income
EBITDA Margin8.2%none · Q2FY27 · reported EBITDA margin
Basic Chemicals EBITDA₹20 Crsequential · Q2FY27 · vs negative ₹14 Cr in Q1FY27
Finance Costs₹13.6 Cr-12.5%yoy · Q2FY27
Finance Costs₹13.6 Cr-8%qoq · Q2FY27
Cash and Cash Equivalents & Investments₹297 Crpoint_in_time · Q2FY27 · as of Sep-2026
Gross Debt₹323 Crpoint_in_time · Q2FY27 · as of Sep-2026
Net Debt₹26 Crpoint_in_time · Q2FY27 · as of Sep-2026
H1FY27 Revenue from Operations₹1,205 Cr+19%yoy · H1FY27
H1FY27 EBITDA₹96 Cr-20%yoy · H1FY27

Guidance

Management expects H2FY27 to be significantly stronger than H1, guiding for double-digit EBITDA margins in the second half.

What management committed to

Key themes

Commodity spread recovery and specialty expansion

How the narrative shifted

Operational commentary

Analyst Q&A

View source

Research and educational content only. Not investment advice.